EQUITY.GURU podcast - Investing for millennials and madmen
Business:Investing
Welcome to the second installment!
Developing new prescription medicine for market is a costly and oftentimes, a futile endeavor as drugmakers can spend up to $2.6 billion only to see 12% of their candidates gain approval. When Pfizer fails on two out of three new drugs, retail investors have grown leery of the space, but companies like Aequus Pharmaceuticals (AQS.V) have found a way to bypass this massive regulatory and financial bottleneck by seeking out existing drugs approved in other countries and bringing them to Canada for market approval.
Spending 12-18 months rather than the standard 8-10 years for new drug approval, Aequus also benefits from low fixed costs that allow the company to profitably operate in a relatively small marketplace such as Canada in niche areas including neurology, ophthalmology and transplant. Positioned for growth with $2.0 million cash in the till, Aequus is a steady bet in an uncertain industry. As such, Equity Guru’s own Chris Parry spoke with company CEO and chairman, Doug Janzen, to get a better look at Aequus unique de-risked approach and its potential for investors. Listen in!
Equity.Guru podcast: Pasha Brands (CRFT.C) helps to make premium grey market bud legal again with new Health Canada program
Equity.Guru podcast: Weekly Crypto Countdown July 5, 2019
Equity Guru podcast: The week in weed ICYMI (July 5, 2019)
Equity.Guru podcast: Yield Growth (BOSS.C) conducts all-out assault on wellness sector with beautiful cannabis-based formulas
Equity.Guru podcast: Nexus Gold (NXS.V) adds to West African assets with Canadian acquisition as gold runs with the bulls
Equity.Guru podcast: Hemptown Organics grows buttloads of high-grade hemp on road to IPO
Equity.Guru podcast: News extra - Slack's (WORK.NYSE) mulit-billion-dollar public market debut
Equity.Guru podcast: Great Bear Resources (GBR.V) proving up high-grade gold project near Red Lake
Equity.Guru podcast: News extra - Canada's new edible legislation and its impact
Equity.Guru podcast: GTEC Holdings’ (GTEC.V) grand plan to build customer loyalty
Equity.Guru podcast: Renaissance Oil (ROE.V) partners with Russian giant in Mexico
Equity.Guru podcast: Cannabis brand king, Marc Lustig, outlines direction for Origin House (OH.C) in wake of $1.1 billion acquisition
Equity.Guru podcast: Chemesis International (CSI.C) angles for piece of 627 million LatAm cannabis market
Mining investment legend, Rick Rule, on Atlantic Gold (AGB.V), Australian miners, mining M&A and blockchain
Equity.Guru podcast: Khiron Life Sciences (KHRN.V) capitalizing on international cannabis markets
Equity.Guru podcast: Plus Products (PLUS.C) - how to conquer the California cannabis market
EQUITY.GURU podcast: Patriot One Technologies (PAT.T) - the hardware that protects soft targets
Equity.Guru podcast: Barrian Mining (BARI.V) goes public to bring gold mining to millennials
Equity.Guru podcast: VitalHub (VHI.V) builds healthcare solution business for the value investor
Equity.Guru podcast: Ceylon Graphite's (CYL.V) world-class Sri Lankan graphite connection
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
U.S Property Podcast
Aligned Money Show
Dubai Property Podcast
The Ramsey Show
The Clark Howard Podcast